Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;61(8):1403.
doi: 10.3390/medicina61081403.

Barriers and Facilitators to Artificial Intelligence Implementation in Diabetes Management from Healthcare Workers' Perspective: A Scoping Review

Affiliations

Barriers and Facilitators to Artificial Intelligence Implementation in Diabetes Management from Healthcare Workers' Perspective: A Scoping Review

Giovanni Cangelosi et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Diabetes is a global public health challenge, with increasing prevalence worldwide. The implementation of artificial intelligence (AI) in the management of this condition offers potential benefits in improving healthcare outcomes. This study primarily investigates the barriers and facilitators perceived by healthcare professionals in the adoption of AI. Secondarily, by analyzing both quantitative and qualitative data collected, it aims to support the potential development of AI-based programs for diabetes management, with particular focus on a possible bottom-up approach. Materials and Methods: A scoping review was conducted following PRISMA-ScR guidelines for reporting and registered in the Open Science Framework (OSF) database. The study selection process was conducted in two phases-title/abstract screening and full-text review-independently by three researchers, with a fourth resolving conflicts. Data were extracted and assessed using Joanna Briggs Institute (JBI) tools. The included studies were synthesized narratively, combining both quantitative and qualitative analyses to ensure methodological rigor and contextual depth. Results: The adoption of AI tools in diabetes management is influenced by several barriers, including perceived unsatisfactory clinical performance, high costs, issues related to data security and decision-making transparency, as well as limited training among healthcare workers. Key facilitators include improved clinical efficiency, ease of use, time-saving, and organizational support, which contribute to broader acceptance of the technology. Conclusions: The active and continuous involvement of healthcare workers represents a valuable opportunity to develop more effective, reliable, and well-integrated AI solutions in clinical practice. Our findings emphasize the importance of a bottom-up approach and highlight how adequate training and organizational support can help overcome existing barriers, promoting sustainable and equitable innovation aligned with public health priorities.

Keywords: artificial intelligence; diabetes; healthcare workers; public health; scoping review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart.
Figure 2
Figure 2
Barriers and facilitators of AI implementation for diabetes management reported by healthcare professionals.

Similar articles

References

    1. Aschner P., Karuranga S., James S., Simmons D., Basit A., Shaw J.E., Wild S.H., Ogurtsova K., Saeedi P. The International Diabetes Federation’s Guide for Diabetes Epidemiological Studies. Diabetes Res. Clin. Pract. 2021;172:108630. doi: 10.1016/j.diabres.2020.108630. - DOI - PubMed
    1. World Health Organization Diabetes—Fact Sheets. [(accessed on 13 June 2025)]. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes.
    1. Chen X., Zhang L., Chen W. Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021. BMC Med. 2025;23:48. doi: 10.1186/s12916-025-03890-w. - DOI - PMC - PubMed
    1. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
    1. Nguyen P., Le L.K.-D., Ananthapavan J., Gao L., Dunstan D.W., Moodie M. Economics of Sedentary Behaviour: A Systematic Review of Cost of Illness, Cost-Effectiveness, and Return on Investment Studies. Prev. Med. 2022;156:106964. doi: 10.1016/j.ypmed.2022.106964. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources